South Korea — Ministry of Food and Drug Safety
Tracked across 4 events · 40 articles · First seen May 26, 2026 · Last active Sep 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: The South Korea — Ministry of Food and Drug Safety granted the marketing authorization for eptinezumab in South Korea.
May 26, 2026 · 7 articles
Regulatory
Impact: The South Korea — Ministry of Food and Drug Safety in South Korea granted the Orphan Drug Designation and Global Innovative Products on Fast Track designation to AGAMREE, which will expedite its regulatory review.
Jun 02, 2026 · 6 articles
Business
Impact: Granted marketing authorization for eptinezumab in South Korea, expanding market access.
Jul 20, 2026 · 7 articles
Business
Impact: The company's approval from South Korea's South Korea — Ministry of Food and Drug Safety is a key quality indicator that supports its credibility and market position, indirectly contributing to the IPO's success.
Aug 19, 2026 · 20 articles
ERGEN INTELLIGENCE
Track South Korea — Ministry of Food and Drug Safety live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard